ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
2,448,914
Share change
-52,864
Total reported value
$4,333,000
Put/Call ratio
400%
Price per share
$1.77
Number of holders
26
Value change
-$404,250
Number of buys
13
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q3 2015

As of 30 Sep 2015, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,448,914 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, DAFNA Capital Management LLC, BlackRock Fund Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and SABBY MANAGEMENT, LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.